Yoshinaga H, Benitez A, Takeda S, Fournier M, et al. A Phase 3 open-label study of the efficacy, safety and pharmacokinetics of buccally administered midazolam hydrochloride for the treatment of status epilepticus in pediatric Japanese subjects. Epilepsy Res 2021;174:106651.
PMID: 34020149